Generic Drug Pricing and Procurement: A Policy for Alberta

Aidan Hollis

SPP Research Papers, 2009, vol. 2, issue 1

Abstract: Canadians pay very high prices for generic drugs compared to international norms. The reason is not inefficient or uncompetitive generic drug companies, but provincial government pricing and insurance policies that are distorting the market. This paper by Professor Aidan Hollis, an expert in the economics of pharmaceutical markets, evaluates provincial government policies regarding generic drugs and proposes a new approach which could save governments and private insurers tens of millions of dollars a year.

Date: 2009
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.policyschool.ca/wp-content/uploads/2016/03/hollis-online-feb-09.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:clh:resear:v:2:y:2009:i:1

Access Statistics for this article

More articles in SPP Research Papers from The School of Public Policy, University of Calgary Contact information at EDIRC.
Bibliographic data for series maintained by Bev Dahlby ( this e-mail address is bad, please contact ).